These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 17407795)

  • 21. Safety and efficacy of Sildenafil therapy in children with pulmonary hypertension.
    Karatza AA; Bush A; Magee AG
    Int J Cardiol; 2005 Apr; 100(2):267-73. PubMed ID: 15823634
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Population pharmacokinetics of sildenafil in term neonates: evidence of rapid maturation of metabolic clearance in the early postnatal period.
    Mukherjee A; Dombi T; Wittke B; Lalonde R
    Clin Pharmacol Ther; 2009 Jan; 85(1):56-63. PubMed ID: 18800037
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Do vardenafil and tadalafil have advantages over sildenafil in the treatment of erectile dysfunction?
    Doggrell S
    Int J Impot Res; 2007; 19(3):281-95. PubMed ID: 17183346
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics and pharmacodynamics of sildenafil in a patient treated with human immunodeficiency virus protease inhibitors.
    Aschmann YZ; Kummer O; Linka A; Wenk M; Azzola A; Bodmer M; Krähenbühl S; Haschke M
    Ther Drug Monit; 2008 Feb; 30(1):130-4. PubMed ID: 18223477
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effectiveness of sildenafil citrate (Viagra) and tadalafil (Cialis) on sexual responses in Saudi men with erectile dysfunction in routine clinical practice.
    Ali ST
    Pak J Pharm Sci; 2008 Jul; 21(3):275-81. PubMed ID: 18614424
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of chronic sildenafil in patients with Eisenmenger syndrome versus idiopathic pulmonary arterial hypertension.
    Chau EM; Fan KY; Chow WH
    Int J Cardiol; 2007 Sep; 120(3):301-5. PubMed ID: 17174418
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection and validated quantification of the phosphodiesterase type 5 inhibitors sildenafil, vardenafil, tadalafil, and 2 of their metabolites in human blood plasma by LC-MS/MS--application to forensic and therapeutic drug monitoring cases.
    Rust KY; Wilkens H; Kaiser R; Bregel D; Wilske J; Kraemer T
    Ther Drug Monit; 2012 Dec; 34(6):729-35. PubMed ID: 23128911
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patterns of switching phosphodiesterase type 5 inhibitors in the treatment of erectile dysfunction: results from the Erectile Dysfunction Observational Study.
    Hatzichristou D; Haro JM; Martin-Morales A; von Keitz A; Riley A; Bertsch J; Belger M; Wolka AM; Beardsworth A;
    Int J Clin Pract; 2007 Nov; 61(11):1850-62. PubMed ID: 17850306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phosphodiesterase 5 inhibitors in vascular systemic disorders.
    Allanore Y
    Joint Bone Spine; 2012 Jul; 79(4):338-40. PubMed ID: 22410367
    [No Abstract]   [Full Text] [Related]  

  • 30. Phosphodiesterase type 5 inhibitors for pulmonary arterial hypertension.
    Archer SL; Michelakis ED
    N Engl J Med; 2009 Nov; 361(19):1864-71. PubMed ID: 19890129
    [No Abstract]   [Full Text] [Related]  

  • 31. [Phosphodiesterase type 5 inhibitors in the treatment of pulmonary arterial hypertension].
    Kiliçkesmez K; Küçükoğlu MS
    Anadolu Kardiyol Derg; 2010 Sep; 10 Suppl 2():16-8. PubMed ID: 20819751
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sildenafil for pulmonary hypertension secondary to congenital heart diseases.
    Gupta A; Kerkar P
    Indian Heart J; 2007; 59(4):342-5. PubMed ID: 19126940
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Simultaneous assay of sildenafil and desmethylsildenafil in neonatal plasma by ultra-performance liquid chromatography-tandem mass spectrometry.
    Witjes BC; Ahsman MJ; van der Nagel BC; Tibboel D; Mathot RA
    Biomed Chromatogr; 2010 Feb; 24(2):180-5. PubMed ID: 19609867
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety and efficacy of transition from subcutaneous treprostinil to oral sildenafil in patients with pulmonary arterial hypertension.
    Keogh AM; Jabbour A; Weintraub R; Brown K; Hayward CS; Macdonald PS
    J Heart Lung Transplant; 2007 Nov; 26(11):1079-83. PubMed ID: 18022071
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sildenafil in Eisenmenger syndrome: safety first.
    Wort SJ
    Int J Cardiol; 2007 Sep; 120(3):314-6. PubMed ID: 17477991
    [No Abstract]   [Full Text] [Related]  

  • 36. One year efficacy and safety of oral sildenafil treatment in severe pulmonary hypertension.
    Samarzija M; Zuljević E; Jakopović M; Sever B; Knezević A; Dumija Z; Vidjak V; Samija M
    Coll Antropol; 2009 Sep; 33(3):799-803. PubMed ID: 19860106
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effectiveness duration determines selection].
    MMW Fortschr Med; 2006 Jul; 148(29-30):54-5. PubMed ID: 16910411
    [No Abstract]   [Full Text] [Related]  

  • 38. Use of sildenafil to facilitate weaning from inhaled nitric oxide in children with pulmonary hypertension following surgery for congenital heart disease.
    Lee JE; Hillier SC; Knoderer CA
    J Intensive Care Med; 2008; 23(5):329-34. PubMed ID: 18701525
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sustained long-term benefit of sildenafil in primary pulmonary hypertension.
    Sayin T; Ozenci M
    Acta Cardiol; 2007 Feb; 62(1):47-9. PubMed ID: 17375892
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tadalafil (Adcirca) for pulmonary arterial hypertension.
    Med Lett Drugs Ther; 2009 Nov; 51(1324):87-8. PubMed ID: 19890245
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.